Concepedia

LBA80 Tislelizumab (TIS) plus chemotherapy (Chemo) vs placebo (PBO) plus chemo as first-line (1L) treatment of advanced gastric or gastroesophageal junction adenocarcinoma (GC/GEJC): Final analysis results of the RATIONALE-305 study

R-H. Xu, D-Y. Oh, Ken Kato, Tobias Arkenau, Josep Tabernero, Marcia Cruz‐Correa, A. Zimina, Yuxian Bai, Jingwen Shi, Kyung-Woo Lee,

Annals of Oncology · 2023 · 16 citations · 0 references

DOI

Concepts